1. Academic Validation
  2. A retro-inverso cell-penetrating peptide for siRNA delivery

A retro-inverso cell-penetrating peptide for siRNA delivery

  • J Nanobiotechnology. 2017 Apr 28;15(1):34. doi: 10.1186/s12951-017-0269-2.
Anaïs Vaissière 1 Gudrun Aldrian 2 Karidia Konate 1 Mattias F Lindberg 1 Carole Jourdan 1 Anthony Telmar 1 Quentin Seisel 1 Frédéric Fernandez 3 Véronique Viguier 3 Coralie Genevois 4 Franck Couillaud 4 Prisca Boisguerin 1 Sébastien Deshayes 5
Affiliations

Affiliations

  • 1 Centre de Recherche de Biologie cellulaire de Montpellier, UMR 5237 CNRS, 1919 Route de Mende, 34293, Montpellier, France.
  • 2 Sys2Diag, UMR 9005-CNRS/ALCEDIAG, 1682 Rue de la Valsiere, 34184, Montpellier, France.
  • 3 Microscopie Électronique et Analytique, Université de Montpellier, Place Eugène Bataillon, 34095, Montpellier, France.
  • 4 EA 7435 IMOTION (Imagerie moléculaire et thérapies innovantes en oncologie), Université de Bordeaux, 146 rue Leo Saignat, 33076, Bordeaux, France.
  • 5 Centre de Recherche de Biologie cellulaire de Montpellier, UMR 5237 CNRS, 1919 Route de Mende, 34293, Montpellier, France. Sebastien.Deshayes@crbm.cnrs.fr.
Abstract

Background: Small interfering RNAs (siRNAs) are powerful tools to control gene expression. However, due to their poor cellular permeability and stability, their therapeutic development requires a specific delivery system. Among them, Cell-penetrating Peptides (CPP) have been shown to transfer efficiently siRNA inside the cells. Recently we developed amphipathic Peptides able to self-assemble with siRNAs as peptide-based nanoparticles and to transfect them into cells. However, despite the great potential of these Drug Delivery systems, most of them display a low resistance to proteases.

Results: Here, we report the development and characterization of a new CPP named RICK corresponding to the retro-inverso form of the CADY-K peptide. We show that RICK conserves the main biophysical features of its L-parental homologue and keeps the ability to associate with siRNA in stable peptide-based nanoparticles. Moreover the RICK:siRNA self-assembly prevents siRNA degradation and induces inhibition of gene expression.

Conclusions: This new approach consists in a promising strategy for future in vivo application, especially for targeted Anticancer treatment (e.g. knock-down of cell cycle proteins). Graphical abstract RICK-based nanoparticles: RICK Peptides and siRNA self-assemble in peptide-based nanoparticles to penetrate into the cells and to induce target protein knock-down.

Keywords

Cancer; Cell penetrating peptides; D-Amino acids; Enantiomer; Gene knock-down; Nanoparticle; Retro-inverso; siRNA delivery.

Figures
Products